About
Built for investors who have a live deal and a thin science bench.
BioticaBio is run by John Round. We take one biotech or medtech package, pull the claims that have to hold for the check to make sense, test them against published science and known failures, and hand you a memo with sources for the partner meeting.
Background
- Diligence and investment decision support across cell therapy, extracellular vesicles, monoclonal antibodies, nucleotide therapeutics, diagnostics, and HCTP-regulated tissue technologies. Prior work includes claim testing against linked biomedical evidence—not deck paraphrasing.
- Venture and corporate life-science strategy: commercial assessment, diligence support, and decision materials for therapeutics and diagnostics.
- Focus on questions that change the call, not questions that pad a memo.
- Entrepreneur in Residence at RI Bio (southeastern New England life-sciences community).
- Client names, deal details, and investment outcomes stay off this site unless a case study is cleared for publication.
Specialists
If the package needs FTO, regulatory sign-off, deep CMC, clinical statistics, or a KOL panel, we say so in the memo and keep those opinions separately scoped. We do not substitute for them.
Conflicts
We run a conflict check before confidential work. Undisclosed concurrent advisory relationships that create a conflict are grounds to decline. Scope and data handling sit in the engagement letter.
Start a fit conversation
Email after you confirm fit, or use the six-field non-confidential form. Do not send data-room files on first contact.